Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

NCT02241187 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: PEGPH20
DRUG: Cetuximab
DEVICE: DW & DCE-MRI
OTHER: blood draws

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]